HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei-Bing Shi Selected Research

WB1106

12/2007WB1106, a novel nitric oxide-releasing derivative of telmisartan, inhibits hypertension and improves glucose metabolism in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei-Bing Shi Research Topics

Disease

1Fibrosis (Cirrhosis)
01/2022
1Chronic Hepatitis B
01/2022
1Body Weight (Weight, Body)
12/2007
1Cardiovascular Diseases (Cardiovascular Disease)
12/2007
1Hypertension (High Blood Pressure)
12/2007
1Insulin Resistance
12/2007
1Pancreatic Neoplasms (Pancreatic Cancer)
05/2002
1Neoplasms (Cancer)
05/2002

Drug/Important Bio-Agent (IBA)

1bushen jianpiIBA
01/2022
1entecavirFDA Link
01/2022
1Hepatitis B e AntigensIBA
01/2022
1Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2022
1AngiotensinsIBA
12/2007
1Antihypertensive Agents (Antihypertensives)IBA
12/2007
1CarbohydratesIBA
12/2007
1Glucose (Dextrose)FDA LinkGeneric
12/2007
1Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2007
1WB1106IBA
12/2007
1Telmisartan (Micardis)FDA Link
12/2007
1GadoliniumIBA
05/2002

Therapy/Procedure

1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022